Epstein Secrets

xanda Kotey and El Shafee Elsheikh to US authorities." The New York Times <https://www.nytimes.com/2020/09/22/us/politics/isis-beatles.html> (9/22, Savage, 18.61 M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

fore reaching the final goal of 164." Modema won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

le Paid Him For "Raw Intelligence." The New York Times <https://vvww.nytimes.com/2020/10/21/us/politics/igor-danchenko-steele-dossier.html> (10/21, Savage, Goldman, Kessel, 18.61M) reports that "when the publication of a dossier of unproven rumors about Donald J. Trump and Russia rocked American politi

potential vaccines." According to the AP, Brazil's health minister Eduardo Pazuello "had announced the purchase on Tuesday." Brazilian Volunteer In AstraZeneca Vaccine Trial Dies. The CBS Evening News <https://playvideo.bulletinintelligence.corn/93052blfaf294 1 1 la0d8d20e31407e5c?pubid=fbi> (10/21, story 4

inees" sought to "assure lawmakers that the Justice Department would remain politically independent on his watch." The New York Times (2/22, Benner, Savage, 20.6M) reports Garland "vowed to uphold the independence of a Justice Department that had suffered deep politicization under the Trump administrat

2/22, Jamison, 10.52M) reports that in Baltimore, Emergent BioSolutions "is manufacturing almost all of the yet-to-be approved Johnson & Johnson and AstraZeneca coronavirus vaccines for the U.S. population - an anticipated hundreds of millions of doses in the coming months." But "in a sign of the complexiti

m this corruption where they get caught." Russian Analyst Behind Dossier Claims Steele Paid Him For "Raw Intelligence." The New York Times (10/21, Savage, Goldman, Kessel, 18.61M) reports that "when the publication of a dossier of unproven rumors about Donald J. Trump and Russia rocked American polit

potential vaccines." According to the AP, Brazil's health minister Eduardo Pazuello "had announced the purchase on Tuesday." Brazilian Volunteer In AstraZeneca Vaccine Trial Dies. The CBS Evening NewsVi (10/21, story 4, 0:25, O'Donnell, 4.55M) reported, "Tonight, health officials in Brazil report that a vo

firmed the transfer of the evidence regarding alleged militants Alexanda Kotey and El Shafee Elsheikh to US authorities." The New York Times (9/22, Savage, 18.61M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

trzok wrote, "Again, we are unaware of ANY Trump advisors engaging in conversations with Russian intelligence officials." The New York Times (7/17, Savage, Goldman, 18.61M) reported documents released on Friday "showed a top FBI agent recognized by February 2017 that a now notorious dossier of claims

accine." CBS (Tyab) added, "The Serum Institute of India is the world's largest manufacturer of vaccines and has been tapped by pharmaceutical giant AstraZeneca to produce over a billion doses of the vaccine being trialed by Oxford University." If the trials are successful, "there is still serious concerns

firmed the transfer of the evidence regarding alleged militants Alexanda Kotey and El Shafee Elsheikh to US authorities." The New York Times (9/22, Savage, 18.61M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro